Nectar Lifesciences

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue385.05364.57443.00476.23403.02
Expenses363.96351.27410.69441.36375.91
EBITDA21.0913.3032.3134.8727.11
EBIT6.81-0.8518.0320.6112.41
Profit Before Tax0.490.3915.2217.986.11
Net Profit1.791.869.7311.663.90
Financial Ratios
Operating Profit Margin5.48%3.65%7.29%7.32%6.73%
Net Profit Margin0.46%0.51%2.20%2.45%0.97%
Earning Per Share (Diluted)0.080.080.430.510.17
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI